Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics, UK Institutions Partner on Clinical Genomic Analysis

NEW YORK (GenomeWeb) – Sophia Genetics announced five partnerships with UK healthcare institutions for use of the company's data analysis platform to clinically interpret genetic information. 

The deals are with Oxford University Hospital, Newcastle Medical Genetics, Aberdeen Medical Genetics, Liverpool Women's NHS Foundation Trust, and New Gene. They will use Sophia's Data Driven Medicine Platform, which employs machine learning and algorithms to analyze patients' genomic samples. 

Christine Bell, a healthcare scientist and principal consultant for Aberdeen Medical Genetics, said in a statement that Sophia's technology has allowed it to investigate and validate its gene panel "more quickly and with greater confidence than we could have done on our own, speeding up the process of introducing the new NGS test to our routine service." 

In April, Lausanne, Switzerland-based Sophia reached deals with University Hospitalin Düsseldorf, Germany and University Hospital Cologne, Germany to use the company's platform to run and validate an NGS-based test for hereditary breast and ovarian cancer. 

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.